Reuters logo
BRIEF-OncoCyte successfully completes a validation study of its diagnostic test for lung cancer​
September 27, 2017 / 11:24 AM / 3 months ago

BRIEF-OncoCyte successfully completes a validation study of its diagnostic test for lung cancer​

Sept 27 (Reuters) - Oncocyte Corp:

* OncoCyte Corp - ‍co’s CLIA laboratory has successfully completed a validation study of Determavu™, OncoCyte’s diagnostic test for lung cancer​

* OncoCyte Corp - ‍clinical validation study has now begun and is expected to be completed in Q4 of 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below